GeneBlocs are powerful tools to study and delineate signal transduction processes that regulate cell growth and transformation

Antisense and Nucleic Acid Drug Development

Volumn 12, Issue 3, 2002, Pages 131-143

  Sternberger, Maria ^a   Schmiedeknecht, Anett ^a   Kretschmer, Anny ^a   Gebhardt, Frank ^a   Leenders, Frauke ^a   Czauderna, Frank ^a   von Carlowitz, Ira ^b   Engle, Mike ^b   Giese, Klaus ^a   Beigelman, Leonid ^c   Klippel, Anke ^a  

^a Atugen AG   (Germany)

^b Atugen AG   (United States)

^c Sirna Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ANTISENSE OLIGONUCLEOTIDE; APHIDICOLIN; GENEBLOC; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; REAGENT; UNCLASSIFIED DRUG; PHOSPHATASE; PTEN PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG SPECIFICITY; EMBRYO; ENZYME ACTIVATION; ENZYME SUBUNIT; GENE EXPRESSION REGULATION; GENE FUNCTION; GROWTH REGULATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; APOPTOSIS; CELL CYCLE S PHASE; CELL DIVISION; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETIC PROCEDURES; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PHYSIOLOGY; RADIATION EXPOSURE; ULTRAVIOLET RADIATION;

ANIMALIA; MAMMALIA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC TECHNIQUES; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PTEN PHOSPHOHYDROLASE; RATS; S PHASE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; ULTRAVIOLET RAYS;

EID: 0035992694     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729002760220734     Document Type: Article

References (43)

1. Antisense therapeutics
2. Mixed backbone oligonucleotides: Improvement in oligonucleotide-induced toxicity in vivo
3. Gatekeeper for endometrium: The PTEN tumor suppressor gene
4. Heterotransplantation studies with tissue culture cell lines in various animal and in vitro host systems
5. Chemical modification of hammerhead ribozymes. Catalytic activity and nuclease resistance
6. Antisense oligonucleotides: Is the glass half full or half empty?
7. Design and application of antisense oligonucleotides in cell culture, in vivo, and as therapeutic agents
8. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide3-kinase/AKT pathway
9. Rate of degradation of [alpha]- and [beta]-oligodeoxynucleotides in Xenopus oocytes. Implications for anti-messenger strategies
10. Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation
11. In vitro toxicology and pharmacokinetics of antisense oligonucleotides
12. Progress in antisense oligonucleotide therapeutics
13. Cellular survival: A play in three Akts
14. PTEN is essential for embryonic development and tumour suppression
15. On the quality control of antisense oligonucleotides
16. Use of partially phosphorothioated "antisense" oligodeoxynucleotides for sequence-dependent modulation of hematopoiesis in culture
17. High-pressure liquid chromatography in polynucleotide synthesis
18. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC
19. Abasic oligodeoxyribonucleoside phosphorothioates: Synthesis and evaluation as anti-HIV-1 agents
20. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1
21. Rat cell line 3Y1 and its virogenic polyoma- and SV40-transformed derivatives
22. The interaction of small domains between the subunits of phosphatidylinositol 3-kinase determines enzyme activity
23. Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation
24. Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase
25. Activation of protein kinase B induced by H(2)O(2) and heat shock through distinct mechanisms dependent and independent of phosphatidylinositol 3-kinase
26. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt
27. Critical issues in the antisense inhibition of brain gene expression in vivo: Experiences targetting the 5-HTIA receptor
28. Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties
29. Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras
30. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells
31. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
32. Phosphatidylinositol 3-kinases in tumor progression
33. PIK3CA is implicated as an oncogene in ovarian cancer
34. Oligodeoxynucleotides as inhibitors of gene expression: A review
35. Physicochemical properties of phosphorothioate oligodeoxynucleotides
36. PI3-kinase inhibition: A target for drug development?
37. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice
38. The PTEN tumor suppressor protein: An antagonist of phosphoinositide 3-kinase signaling
39. Oligodeoxynucleotide stability in subcellular extracts and culture media
40. Synthesis, deprotection, analysis and purification of RNA and ribozymes
41. The stability, toxicity and effectiveness of unmodified and phosphorothioate antisense oligodeoxynucleotides in Xenopus oocytes and embryos
42. Antisense phosphorothioate oligodeoxynucleotides: Introductory concepts and possible molecular mechanisms of toxicity